Compounds > hmn-176
Page last updated: 2024-11-12

hmn-176

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

(E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12134997
SCHEMBL ID5173597
MeSH IDM0467694

Synonyms (17)

Synonym
173529-10-7
(e)-4-((2-n-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide
hmn-176
(e)-4-((2-n-(4-methoxybenzenesulfonyl)amino)stilbazole) 1-oxide
benzenesulfonamide, 4-methoxy-n-(2-((1e)-2-(1-oxido-4-pyridinyl)ethenyl)phenyl)-
(e)-4-(2-(2-(n-((p-methoxyphenyl)sulfonyl)amino)phenyl)ethenyl)pyridine 1-oxide
benzenesulfonamide, 4-methoxy-n-(2-(2-(1-oxido-4-pyridinyl)ethenyl)phenyl)-, (e)-
hmn 176
SCHEMBL5173597
EX-A1159
4-methoxy-n-[2-[(1e)-2-(1-oxido-4-pyridinyl)ethenyl]phenyl]benzenesulfonamide
(e)-4-(2-((4-methoxyphenyl)sulfonamido)styryl)pyridine 1-oxide
(ne)-n-[(6e)-6-[2-(1-hydroxypyridin-4-ylidene)ethylidene]cyclohexa-2,4-dien-1-ylidene]-4-methoxybenzenesulfonamide
BS-15653
A907297
n-{(1z,6e)-6-[2-(1-hydroxy-4(1h)-pyridinylidene)ethylidene]-2,4-cyclohexadien-1-ylidene}-4-methoxybenzenesulfonamide
YGA52910
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.72 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index61.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
stilbenes
Stilbenes: Organic compounds that contain 1,2-diphenylethylene as a functional group.. trans-stilbene : The trans-isomer of stilbene.		3.4111stilbene
hmn-214
(E)-4-(2-(2-(N-acetyl-N-(4-methoxybenzenesulfonyl)amino)stilbazole)) 1-oxide: an antineoplastic agent; structure in first source		8.8121
ConditionIndicatedRelationship StrengthStudiesTrials
Cancer of Ovary
[description not available]		02.0110
Ovarian Neoplasms
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.		02.0110
Benign Neoplasms
[description not available]		03.8221
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.		03.8221
Disease Exacerbation
[description not available]		03.4111